Building Biocompatible Hydrogels for Tissue Engineering of the Brain and Spinal Cord
Source abstract
Abstract
Tissue engineering strategies employing biomaterials have made great progress in the last few decades. However, the tissues of the brain and spinal cord pose unique challenges due to a separate immune system and their nature as soft tissue. Because of this, neural tissue engineering for the brain and spinal cord may require re-establishing biocompatibility and functionality of biomaterials that have previously been successful for tissue engineering in the body. The goal of this review is to briefly describe the distinctive properties of the central nervous system, specifically the neuroimmune response, and to describe the factors which contribute to building polymer hydrogels compatible with this tissue. These factors include polymer chemistry, polymerization and degradation, and the physical and mechanical properties of the hydrogel. By understanding the necessities in making hydrogels biocompatible with tissue of the brain and spinal cord, tissue engineers can then functionalize these materials for repairing and replacing tissue in the central nervous system.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Tissue Engineering and Regenerative Medicine · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Neuroscience Program and Department of Pediatrics, University of Colorado-Denver, Anschutz Medical Campus, Mail Stop 8313, 12800 E. 19th Avenue, Aurora, CO 80045, USA
Department of Bioengineering, University of Colorado-Denver, Anschutz Medical Campus, Mail Stop 8607, 12700 E. 19th Avenue, Aurora, CO 80045, USA
References (100+)
Show source-provided references
1. The brain tissue response to biodegradable poly(methylidene malonate 2.1.2)-based microspheres in the rat10.1016/j.biomaterials.2006.04.045 ↗
2. Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles10.1023/A:1018986226557 ↗
3. Human immunodeficiency virus infection of human astrocytes disrupts blood–brain barrier integrity by a gap junction-dependent mechanism10.1523/JNEUROSCI.1460-11.2011 ↗
4. Multiple sclerosis10.1007/978-1-4614-0653-2_17 ↗
5. Hydrogel matrix to support stem cell survival after brain transplantation in stroke10.1177/1545968310361958 ↗
6. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum10.1006/exnr.1996.0141 ↗
7. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of parkinson’s disease10.1016/j.expneurol.2008.01.025 ↗
8. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat10.1007/s002210050350 ↗
9. Cellular repair in the parkinsonian nonhuman primate brain10.1089/rej.2009.0960 ↗
10. Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer10.1002/stem.26 ↗
11. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex10.1073/pnas.0404474101 ↗
12. The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting10.1016/j.brainres.2009.07.079 ↗
13. Survival, differentiation, and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural stem cells derived from embryonic stem cells10.1002/jnr.22193 ↗
14. Effects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the ts65dn model of down syndrome10.1371/journal.pone.0036082 ↗
15. Functional engraftment of human es cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes10.1038/nm1495 ↗
16. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats10.1016/S0006-8993(98)00717-3 ↗
17. Dopaminergic neuronal survival and the effects of bfgf in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon10.1007/BF00241123 ↗
18. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of parkinson’s disease: Impaired graft survival is associated with high baseline rotational behavior10.1006/exnr.1993.1102 ↗
19. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces10.1177/096368970000900310 ↗
20. Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell-derived neural precursor cells10.1002/jnr.22223 ↗
21. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain10.1002/term.154 ↗
22. Biomimetic material systems for neural progenitor cell-based therapy10.2741/2721 ↗
23. Transplantation of human neural precursor cells in matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats10.1038/jcbfm.2009.219 ↗
24. Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system10.1039/c0sm00448k ↗
25. The support of neural stem cells transplanted into stroke-induced brain cavities by plga particles10.1016/j.biomaterials.2009.02.012 ↗
26. Mechanical properties of hydrogels and their experimental determination10.1016/0142-9612(96)87644-7 ↗
27. Defining and designing polymers and hydrogels for neural tissue engineering10.1016/j.neures.2011.12.005 ↗
28. Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks10.1021/bm049508a ↗
29. Hydrogels for tissue engineering: Scaffold design variables and applications10.1016/S0142-9612(03)00340-5 ↗
30. Biocompatible hydrogels in spinal cord injury repair10.33549/physiolres.931606 ↗
31. Mechanical properties of cellularly responsive hydrogels and their experimental determination10.1002/adma.200904179 ↗
32. Photopolymerizable hydrogels for tissue engineering applications10.1016/S0142-9612(02)00175-8 ↗
33. Biomaterials for brain tissue engineering10.1071/CH10159 ↗
34. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation10.1016/j.biomaterials.2010.01.125 ↗
35. Hydrogels in regenerative medicine10.1002/adma.200802106 ↗
36. Hyaluronic acid-poly-d-lysine-based three-dimensional hydrogel for traumatic brain injury10.1089/ten.2005.11.513 ↗
37. Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering10.1002/mabi.200800141 ↗
38. Review: Glial lineages and myelination in the central nervous system10.1046/j.1469-7580.1997.19020161.x ↗
39. Opposing roles for reactive astrocytes following traumatic brain injury10.1159/000111560 ↗
40. Immune function of microglia10.1002/glia.1106 ↗
41. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain10.1038/nn1997 ↗
42. Cns injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure10.1016/j.expneurol.2007.05.014 ↗
43. On the biogenesis of myelin membranes: Sorting, trafficking and cell polarity10.1016/j.febslet.2009.10.085 ↗
44. Regulation of oligodendrocyte differentiation and myelination10.1126/science.1190927 ↗
45. Genes involved in leukodystrophies: A glance at glial functions10.1007/s11910-008-0034-x ↗
46. Oligodendroglial impact on axonal function and survival—a hypothesis10.1097/WCO.0b013e328300c71f ↗
47. Mechanisms underlying the process of demyelination in multiple sclerosis10.1007/s11062-010-9114-z ↗
48. Dysmyelination revisited10.1001/archneur.1978.00500310003001 ↗
49. In vitro and in vivo characterization of neural stem cells
50. Cell migration in the normal and pathological postnatal mammalian brain10.1016/j.pneurobio.2009.02.001 ↗
51. Mammalian neural stem cells10.1126/science.287.5457.1433 ↗
52. Current concepts in central nervous system regeneration10.1054/jocn.2002.1080 ↗
53. Klimanskaya, I., and Lanza, R.P. (2006). Adult Stem Cells, Elsevier Academic Press.
54. Characteristics of sustained blood-brain barrier opening and tissue injury in a model for focal trauma in the rat10.1089/089771501750055794 ↗
55. Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: An analysis of the glial response across space and time10.1002/jbm.a.32809 ↗
56. Reactive astrocytes: Cellular and molecular cues to biological function10.1016/S0166-2236(97)01139-9 ↗
57. Glial reactivity after damage: Implications for scar formation and neuronal recovery
58. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor10.1523/JNEUROSCI.19-05-01708.1999 ↗
59. Characterization of microglial attachment and cytokine release on biomaterials of differing surface chemistry10.1016/j.biomaterials.2008.03.045 ↗
60. Biocompatibility of implantable synthetic polymeric drug carriers: Focus on brain biocompatibility10.1016/S0142-9612(03)00161-3 ↗
61. Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system10.1016/j.biomaterials.2009.01.056 ↗
62. Davies, J., Huang, C., Proschel, C., Noble, M., Mayer-Proschel, M., and Davies, S. (2006). Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol., 5.10.1186/jbiol35 ↗
63. Growth promoting and inhibitory effects of glial cells in the mammalian nervous system10.1007/978-1-4615-4685-6_16 ↗
64. No tissue damage by chronic deep brain stimulation in parkinson’s disease10.1002/1531-8249(200009)48:3<372::AID-ANA12>3.0.CO;2-0 ↗
65. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion10.1016/j.biocel.2004.01.013 ↗
66. Reduction of neurite outgrowth in a model of glial scarring following cns injury is correlated with the expression of inhibitory molecules on reactive astrocytes10.1523/JNEUROSCI.11-11-03398.1991 ↗
67. Transcriptional regulation of scar gene expression in primary astrocytes10.1002/glia.20537 ↗
68. Brain extracellular matrix in neurodegeneration10.1111/j.1750-3639.2008.00195.x ↗
69. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin10.1016/j.jneumeth.2005.04.016 ↗
70. Extracellular matrix components associated with remodeling processes in brain10.1007/s00018-004-4043-x ↗
71. Brain extracellular matrix10.1093/glycob/6.5.489 ↗
72. Fibronectin supports neurite outgrowth and axonal regeneration of adult brain neurons in vitro10.1016/j.brainres.2012.03.024 ↗
73. Davies, J., Proschel, C., Zhang, N., Noble, M., Mayer-Proschel, M., and Davies, S. (2008). Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J. Biol., 7.10.1186/jbiol85 ↗
74. Biocompatibility of peg-based hydrogels in primate brain10.3727/096368908784423292 ↗
75. The administration of bdnf and gdnf to the brain via plga microparticles patterned within a degradable peg-based hydrogel: Protein distribution and the glial response10.1002/jbm.a.33011 ↗
76. Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury10.1089/neu.2007.0377 ↗
77. A lack of amyloid β plaques despite persistent accumulation of amyloid β in axons of long-term survivors of traumatic brain injury10.1111/j.1750-3639.2008.00176.x ↗
78. Long-term intracerebral inflammatory response after traumatic brain injury10.1016/j.forsciint.2004.06.027 ↗
79. Inflammatory response in acute traumatic brain injury: A double-edged sword10.1097/00075198-200204000-00002 ↗
80. Enderle, J.D., Blanchard, S.M., and Bronzino, J.D. (2005). Introduction to Biomedical Engineering, Elsevier Academic Press. [2nd].
81. Materials for central nervous system regeneration: Bioactive cues10.1039/c0jm04335d ↗
82. Synthetic polymers for biopharmaceutical delivery10.1039/C0PY00210K ↗
83. Hydrogels in biology and medicine: From molecular principles to bionanotechnology10.1002/adma.200501612 ↗
84. Synthetic polymer scaffolds for tissue engineering10.1039/b811392k ↗
85. Polymeric hydrogels placed into a fimbria-fornix lesion cavity promote fiber (re)growth: A morphological study in the rat
86. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine10.1016/j.jconrel.2011.04.007 ↗
87. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering10.1002/jbm.a.30831 ↗
88. In situ polymerization of tropoelastin in the absence of chemical cross-linking10.1016/j.biomaterials.2008.10.018 ↗
89. Injectable biodegradable hydrogels10.1002/mabi.200900402 ↗
90. In vivo degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds10.1016/j.biomaterials.2004.11.039 ↗
91. Tissue-biomaterial interactions10.1007/BF01161439 ↗
92. Impact of lactic acid on cell proliferation and free radical-induced cell death in monolayer cultures of neural precursor cells10.1002/bit.22352 ↗
93. Toward an enhanced understanding and implementation of photopolymerization reactions10.1002/aic.11678 ↗
94. Impact of degradable macromer content in a poly(ethylene glycol) hydrogel on neural cell metabolic activity, redox state, proliferation, and differentiation10.1089/ten.tea.2009.0509 ↗
95. Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation10.1016/j.biomaterials.2004.04.024 ↗
96. Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults10.1089/ars.2010.3629 ↗
97. Ph-triggered injectable hydrogels prepared from aqueous n-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility10.1016/j.biomaterials.2009.05.052 ↗
98. Thermoreversible gelation of peg-plga-peg triblock copolymer aqueous solutions10.1021/ma9908999 ↗
99. In situ gelation of peg-plga-peg triblock copolymer aqueous solutions and degradation thereof10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F ↗
100. Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability10.1021/bm1004299 ↗